1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Ringer solution: new trials by email Literature Review of Ringer solution trials Research Report on Ringer solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19) Tissue plasminogen activator, Ringer solution - Acute Respiratory Distress Syndrome | Phase 3 | Withdrawn | Negovsky Reanimatology Research Institute | 2020-10-15 | 2021-03-12 |
COVID-19 (1) · Respiratory Distress Syndrome (1)